Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
61.00
+5.00 (8.93%)
Jun 3, 2026, 3:30 PM JST
TYO:4596 Revenue
Kubota Pharmaceutical Holdings had revenue of 4.00M JPY in the quarter ending March 31, 2026, a decrease of -44.79%. This brings the company's revenue in the last twelve months to 17.76M, down -39.60% year-over-year. In the year 2025, Kubota Pharmaceutical Holdings had annual revenue of 21.00M, down -22.22%.
Revenue (ttm)
17.76M
Revenue Growth
-39.60%
P/S Ratio
363.99
Revenue / Employee
2.22M
Employees
8
Market Cap
6.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.00M | -6.00M | -22.22% |
| Dec 31, 2024 | 27.00M | -12.00M | -30.77% |
| Dec 31, 2023 | 39.00M | 31.00M | 387.50% |
| Dec 31, 2022 | 8.00M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 6.59B |
| Soiken Holdings | 4.40B |
| CellSource | 3.72B |
| StemCell Institute | 2.81B |
| MEDINET | 998.00M |
| OncoTherapy Science | 808.00M |
| Chiome Bioscience | 593.29M |
| ADR120S | 50.00M |